JESSICA VELOZA: Open Payments
NPI 1215639943 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 20 payments from 8 companies in 2025. Trend: 2023 $17 · 2024 $238 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $280 |
| Merck Sharp & Dohme LLC | 8 | $151 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Lilly USA, LLC | 1 | $95 |
| Gilead Sciences, Inc. | 2 | $60 |
| Medline Industries LP | 1 | $52 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: PIFELTRO, AUSTEDO XR, ZEPBOUND, CABENUVA, APRETUDE, DELSTRIGO, NEMLUVIO, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
